NCT00279864View on ClinicalTrials.gov

The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Staphylococcal InfectionStaphylococcus Aureus Prosthetic Joint Infection
Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Ortho-McNeil, Inc.

INDUSTRY

lead

Mayo Clinic

OTHER